Biotech Values

[y3maxx]

""Well, for starters, desperation leads some companies to settle litigation on terms less favorable than they might otherwise be able to get.""

...Unless the FDA approves M copax, MNTA signs a new partnership or it monetizes M enox?

Teva is sure exerting a lot of pressure on the upstart MNTA.

y3